Soligenix Inc. (SNGX)

1 +0.03 (+3.093%)

IEX Real-Time Price

11:40:42 AM EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.97

Price Open 0.98

Volume: 15,389

Avg Volume: 84,450

Market Cap: 17.68M

P/E Ratio -1.79

52 Wk Range 0.91-3.7



SNGX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-08-15
10.28M
391,223
1.44
3.81%

2018-07-31
10.28M
302,341
1.85
2.94%

2018-07-13
9.12M
194,803
0.82
2.14%

2018-06-29
9.12M
931,279
6.41
10.22%




SNGX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-09
Q3 2018
N/A
-0.14 (1)
-0.11
0.03

2018-08-08
Q2 2018
N/A
-0.28 (1)
-0.18
0.10

2018-05-11
Q1 2018
N/A
0.00 (0)
-0.27
0.00

2018-04-02
Q4 2017
N/A
-0.31 (2)
0.00
0.00

News

Soligenix Announces Publication of Scientific Review Discussing Clinical Applications of Innate Defense Regulator Technology (2018-12-05 06:00 PR Newswire)

PRINCETON, N.J. , Dec. 5, 2018 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today publication of a…

 


Statistics

Shares Outstanding: 17.68M

Top 15 Institution Percent: 14.70

Price To Sales: 3.11

Price To Book: 1.85

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -83.16

Return On Equity: -128.16

Profit Margin: N/A

Price History

Beta: 0.92

50-day Moving Avg: 1.29

200-day Moving Avg: 1.50

YTD Change: -56.70

5-day Change: -12.61

1-month Change: -6.73

3-month Change: -34.46

6-month Change: -36.77

1-year Change: -50.26

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Soligenix Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.soligenix.com

Soligenix Inc focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need.